Anzeige
Mehr »
Login
Samstag, 24.07.2021 Börsentäglich über 12.000 News von 669 internationalen Medien
East Africa Metals - Deal mit dem größten Goldproduzenten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PU7C ISIN: US89237H2094 Ticker-Symbol: T051 
Frankfurt
23.07.21
13:55 Uhr
3,220 Euro
-0,040
-1,23 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TRACON PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
TRACON PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,2203,32023.07.

Aktuelle News zur TRACON PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoTRACON Pharma secures $15M capital raise5
DoTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $15.0 Million4
TRACON PHARMACEUTICALS Aktie jetzt für 0€ handeln
MiTRACON slumps 18% on $10M capital raise5
MiTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock1
DiTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Appointment of Brenda Marczi, PharmD, as Senior Vice President, Regulatory Affairs, and ...2
30.06.Tracon Pharmaceuticals, Inc. - 8-K, Current Report1
30.06.TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Programming and Granting of ...-
29.06.TRACON gets Orphan Drug status for envafolimab in soft tissue sarcoma-
29.06.TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Orphan Drug Designation for Envafolimab in Soft Tissue Sarcoma1
11.06.Tracon Pharmaceuticals, Inc. - 8-K, Current Report3
04.06.TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Presents Data from a Phase 1 Study of Uliledlimab (TJ004309) and Tecentriq (Atezolizumab) at the ...-
01.06.TRACON gets positive Independent Data Monitoring Committee recommendation for envafolimab trial-
01.06.TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal ...-
25.05.TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference1
20.05.TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Poster Presentations at the 2021 ASCO Virtual Annual Meeting1
06.05.TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q1 2021 Results - Earnings Call Transcript1
03.05.TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Appointment of Dongliang Zhuang, Ph.D. as Vice President of Statistics and Biometrics1
28.04.TRACON Pharmaceuticals, Inc.: TRACON to Report First Quarter 2021 Financial Results and Company Highlights on May 5, 2021-
23.03.TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Poster Presentation at the 2021 AACR Virtual Annual Meeting2
18.03.TRACON Pharmaceuticals (TCON) Investor Presentation - Slideshow1
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1